| Literature DB >> 25636170 |
Maude E Phipps1,2, Kevin K L Chan3, Rakesh Naidu4, Nazaimoon W Mohamad5, Boon-Peng Hoh6, Kia-Fatt Quek7, Badariah Ahmad8, Siti M I Harnida9, Anuar Z M Zain10, Khalid A Kadir11.
Abstract
BACKGROUND: South East Asia (SEA) is home to over 30 tribes of indigenous population groups who are currently facing rapid socio-economic change. Epidemiological transition and increased prevalence of non-communicable diseases (NCD) has occured. In Peninsular Malaysia, the Orang Asli (OA) indigenous people comprise 0 · 6% (150,000) of the population and live in various settlements. OA comprise three distinct large tribes with smaller sub-tribes. The three large tribes include Proto-Malay (sub-tribes: Orang Seletar and Jakun), Senoi (sub-tribes: Mahmeri and Semai), and Negrito (sub-tribes: Jehai, Mendriq and Batek).Entities:
Mesh:
Year: 2015 PMID: 25636170 PMCID: PMC4314805 DOI: 10.1186/s12889-015-1384-3
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Sample proportions and characteristics of tribes and sub-tribes in various socio-economic groups
|
| ||||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
| ||||||
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
| ||
|
| 636 (100) | 253 (39.1) | 70 (10.8) | 59 (9.1) | 57 (8.8) | 105 (16.2) | 48 (7.4%) | 44 (6.8) |
|
| 31 | 31 | 31 | 37 | 30 | 31 | 30 | 34 |
|
| ||||||||
|
| 275 (43.2) | 91 (36) | 20 (28.6) | 23 (38.6) | 36 (63.2) | 58 (55.2) | 12 (25) | 33 (75) |
|
| 361 (56.8) | 162 (64) | 50 (71.4) | 36 (61.4) | 21 (36.8) | 47 (44.8) | 36 (75) | 11 (25) |
|
| ||||||||
|
| ||||||||
|
|
|
|
|
| ||||
|
| 31 | 31 | 32 | 33 | ||||
|
| ||||||||
|
| 275 (43.2) | 91 (36.0) | 79 (42.5) | 103 (52.3) | ||||
|
| 361 (56.8) | 162 (64.0) | 107 (57.5) | 94 (47.7) | ||||
|
| 636 (100) | 253 | 186 | 197 | ||||
Association between anthropometric and cardiometabolic risk factors by socio-economic groups
|
|
|
|
| ||
|---|---|---|---|---|---|
|
|
|
|
| ||
|
| 22.90 (8.50) |
|
|
| <0.0001 |
|
| 79.0 (22.0) |
|
|
| <0.0001 |
|
| 125 (23) | 123 (24) |
|
| <0.0001 |
|
| 81 (15) |
|
| 84 (15) | <0.0001 |
|
| 4.90 (1.76) |
| 4.81 (1.39) |
| <0.0001 |
|
| 1.18 (0.44) |
| 1.13 (0.38) |
| <0.0001 |
|
| 1.23 (0.77) | 1.22 (0.76) | 1.37 (0.95) | 1.18 (0.79) | 0.642 |
|
| 1.06 (0.86) |
|
|
| <0.0001 |
|
| 5.2 (0.6) [33 (4)] |
|
| 5.2 (0.5) [33 (3)] | <0.0001 |
|
| 5.08 (1.12) |
|
| 4.90 (1.31)§ | < 0.0001 |
|
| 3.20 (3.80) | 3.15 (3.78) | 2.95 (3.30) | N/A | 0.110 |
§Random plasma glucose.
Data in *bold is substantially different in a particular Socio-Economic group, compared to the other/s italicised SE group.
Data expressed as median (interquartile range) with the exception of HbA1c expressed as Median HbA1c%(IQR) [Median mmol/mol (IQR)].
Data calculated using IBM Statistics SPSS v21.0.
Prevalence of cardiometabolic risk factors in various socio-economic groups
|
|
|
| ||
|---|---|---|---|---|
|
|
|
| ||
| HOMA-IR | 61.8 ± 4.9 | 58.1 ± 6.1 | 55.3 ± 9.1 |
|
| (≥2.6) % | ||||
|
| 16.8 ± 3.0 |
| 12.0 ± 4.9 | 2.0 ± 2.0 |
| (>30 kg/m2) % | ||||
|
| 38.4 ± 3.4 |
| 14.9 ± 5.0 | 23.0 ± 5.9 |
| (M: Waist >90 cm | ||||
| F: Waist >80 cm) % | ||||
|
| 29.6 ± 3.6 | 29.4 ± 5.6 | 17.4 ± 5.9 |
|
| (≥140/90 mmHg) % | ||||
|
| 45.8 ± 3.9 | 24.5 ± 5.3 | 49.5 ± 7.1 |
|
| (M: < 1.0 mmol/L | ||||
| F: < 1.3 mmol/L) % | ||||
|
| 23.9 ± 3.3 | 22.5 ± 5.1 | 24.6 ± 6.2 |
|
| (≥1.7 mmol/L) % | ||||
|
| 7.4 ± 2.4 |
| 4.0 ± 2.9 | N/A |
| (FPG 6.1 mmol/L to 6.9 mmol/L) % | ||||
|
| 8.8 ± 2.2 |
| 3.6 ± 2.9 | 2.2 ± 2.2 |
| (≥42 mmol/mol [6.0%]) % | ||||
|
| 4.2 ± 1.6 |
| 1.2 ± 1.7 | 1.1 ± 1.5 |
| (HbA1c 6.0% - 6.4%) % | ||||
|
| 4.6 ± 1.6 |
| 2.4 ± 2.3 | 1.1 ± 1.5 |
| (HbA1c ≥ 6.5%) % | ||||
Highest prevalence recorded in bold numbers.
Data expressed as prevalence at 95% CI using IBM Statistics SPSS v21.0.
Association between anthropometric and cardiometabolic risk factors by tribes and sub-tribes
|
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||
|
|
|
|
|
|
|
|
| ||
|
| 22.90 (8.50) | 27.35 (9.27) | 20.10 (7.50) | 21.74 (10.00) | 22.97 (4.45) | 20.50 (3.99) | 22.20 (5.50) | 19.20 (2.57) | <0.0001 |
|
| 79.0 (22.0) | 90.0 (24.0) | 69.0 (16.5) | 79.0 (19.5) | 75.5 (12.3) | 71.0 (12.0) | 78.0 (11.0) | 69.0 (8.4) | <0.0001 |
|
| 125 (23) | 123 (23) | 118 (22) | 129 (32) | 118 (22) | 131 (28) | 124 (15) | 134 (22) | <0.0001 |
|
| 81 (15) | 81 (15) | 75 (13) | 83 (28) | 70 (15) | 85 (18) | 79 (15) | 85 (16) | <0.0001 |
|
| 4.90 (1.76) | 5.18 (1.89) | 4.66 (1.47) | 5.18 (1.31) | 5.29 (1.39) | 4.74 (1.16) | 1.98 (0.00) | 1.98 (0.00) | <0.0001 |
|
| 1.18 (0.44) | 1.36 (0.39) | 0.99 (0.36) | 1.28 (0.34) | 1.16 (0.26) | 1.01 (0.32) | 0.90 (0.25) | 0.95 (0.18) | <0.0001 |
|
| 1.23 (0.77) | 1.22 (0.76) | 1.35 (0.98) | 1.47 (1.03) | 1.35 (1.02) | 1.22 (0.89) | 1.33 (1.07) | 1.17 (0.52) | 0.779 |
|
| 1.06 (0.86) | 0.929 (0.620) | 1.227 (1.060) | 1.070 (0.770) | 1.120 (0.850) | 1.273 (1.040) | 1.427 (1.200) | 1.249 (0.790) | <0.0001 |
|
| 5.2 (0.6) [33 (4)] | 5.3 (0.9) [34 (5)] | 5.0 (0.4) [31 (2)] | 5.2 (0.5) [33 (3)] | 5.1 (0.6) [32 (3)] | 5.3 (0.5) [34 (3)] | 4.9 (0.6) [30 (4)] | 5.3 (0.3) [34 (2)] | <0.0001 |
|
| 5.08 (1.12) | 5.28 (0.82) | 4.16 (0.94) | 4.90 (1.00) | 4.89 (0.85) | 5.10 (1.30)§ | 4.46 (0.87)§ | 4.97 (1.29)§ | <0.0001 |
|
| 3.20 (3.80) | 3.15 (3.78) | 2.40 (3.20) | 3.10 (3.50) | N/A | N/A | N/A | N/A | 0.120 |
§Random plasma glucose.
Data expressed as median (interquartile range) with the exception of HbA1c expressed as Median HbA1c%(IQR) [Median mmol/mol (IQR)].
Data calculated using IBM Statistics SPSS v21.0.
Prevalence of cardio metabolic risk factors by tribes and sub-tribes
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
| ||||||
|
|
|
|
|
|
|
| ||
| Obesity (>30 kg/m2) | 16.8% ± 3.0% | 31.6% ± 5.7% | 5.8% ± 5.5% | 27.5% ± 13.8 | 8.8% ± 7.4% | 1.90% ± 2.6% | 4.5% ± 6.1 | 0.0% ± 0.0 |
| Abdominal obesity | 38.4% ± 3.4% | 66.10% ± 5.86% | 29.60% ± 10.7% | 31.10% ± 13.52% | 16.10% ± 9.62% | 13.60% ± 9.5% | 27.30% ± 13.16% | 6.30 ± 6.87 |
| (M: Waist >90 cm | ||||||||
| F: Waist >80 cm) | ||||||||
| Hypertension ≥140/90 mmHg | 29.6% ± 3.6% | 29.4% ± 5.6% | 14.5% ± 8.2% | 35.4% ± 13.5% | 12.3% ± 8.5% | 43.8% ± 9.29% | 16.3% ± 11.0% | 51.2% ± 15.3 |
| Reduced HDL-C | 45.8% ± 3.9% | 24.5% ± 5.3% | 72.9% ± 10.4% | 42.10% ± 12.82% | 33.30% ± 12.23% | 63.90% ± 9.56% | 72.10% ± 13.41% | 77.10% ± 11.89% |
| (M: < 1.0 mmol/L | ||||||||
| F: < 1.3 mmol/L) | ||||||||
| Elevated TG | 23.9% ± 3.3% | 22.5% ± 5.1% | 30.0% ± 10.7% | 16.1% ± 9.6% | 26.3% ± 11.4% | 29.9% ± 9.1 | 27.9% ± 13.4% | 12.5% ± 9.4% |
| (≥1.7 mmol/L) | ||||||||
| IFG | 7.4% ± 2.4% | 9.9% ± 3.7% | 1.4% ± 2.8% | 3.4% ± 4.8% | 7.5% ± 7.1% | N/A | N/A | N/A |
| (FPG 6.1 mmol/L to 6.9 mmol/L) | ||||||||
| High HbA1c | 8.8 ± 2.2 | 18.2% ± 4.8% | 1.5% ± 2.8% | 7.3% ± 8.0% | 3.6% ± 4.9% | 4.2% ± 4.0% | 0.0% ± 0.0 | 0.0% ± 0.0% |
| (≥42 mmol/mol [6.0%]) % | ||||||||
| Pre-Diabetes | 4.2 ± 1.6 | 9.1% ± 3.6% | 1.5% ± 2.9% | 0.0 | 1.8% ± 3.5% | 2.1% ± 2.9% | 0.0 | 0.0 |
| (HbA1C 6.0% - 6.4%) | ||||||||
| Diabetes Mellitus | 4.6 ± 1.6 | 9.1% ± 3.6% | 0.0 | 7.3% ± 8.0% | 1.8% ± 3.5% | 2.1% ± 2.9% | 0.0 | 0.0 |
| (HbA1C ≥ 6.5%) | ||||||||
| Data expressed as prevalence at 95% confidence intervals | ||||||||
| Data calculated using IBM Statistics SPSS v21.0. | ||||||||